| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 1758-1763, Copyright © 1996 by Endocrine Society
ARTICLES |
K Sakai, N Horiba, Y Sakai, F Tozawa, H Demura and T Suda
Department of Medicine, Hirosaki University School of Medicine, Japan.
Adrenalectomy (ADX) leads to a decrease in the number of CRF-binding sites in the rat anterior pituitary (AP). However, the molecular mechanisms of CRF receptor (CRF-R) regulation are unknown. In the present study, we analyzed the effects of ADX on pituitary CRF-R1 messenger RNA (mRNA) levels in vivo and the direct effects of CRF, arginine vasopressin (AVP), and glucocorticoid, the levels of which are altered by ADX, on CRF-R1 mRNA levels in vitro. The mRNA level was determined by Northern blot analysis using a rat brain CRF-R1 complementary RNA probe. The CRF-R1 level in AP fell to 20% of the sham level 1 day after ADX and returned to the sham level after 14 days. In cultured rat AP cells, treatment with CRF, AVP, and dexamethasone led to significant reductions in CRF-R1 mRNA, with maximal inhibition to 32%, 22%, and 37% of control levels, respectively. The time course of CRF-R1 mRNA reduction varied depending on the drug, with effects detectable as early as 1 h after treatment. These findings indicate that elevated portal CRF and AVP levels may contribute to the decrease in CRF-R1 mRNA soon after ADX. A decrease in mRNA levels, in turn, may lead to a decrease in CRF-R1 protein on corticotrophs.
This article has been cited by other articles:
![]() |
K. Kageyama, K. Hanada, T. Moriyama, T. Nigawara, S. Sakihara, and T. Suda G Protein-Coupled Receptor Kinase 2 Involvement in Desensitization of Corticotropin-Releasing Factor (CRF) Receptor Type 1 by CRF in Murine Corticotrophs Endocrinology, January 1, 2006; 147(1): 441 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kageyama, C. Li, and W. W. Vale Corticotropin-Releasing Factor Receptor Type 2 Messenger Ribonucleic Acid in Rat Pituitary: Localization and Regulation by Immune Challenge, Restraint Stress, and Glucocorticoids Endocrinology, April 1, 2003; 144(4): 1524 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Nolan and A. Levy Temporally Sensitive Trophic Responsiveness of the Adrenalectomized Rat Anterior Pituitary to Dexamethasone Challenge: Relationship between Mitotic Activity and Apoptotic Sensitivity Endocrinology, January 1, 2003; 144(1): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Coste, K. A. Heldwein, S. L. Stevens, E. Tobar-Dupres, and M. P. Stenzel-Poore IL-1{alpha} and TNF{alpha} Down-Regulate CRH Receptor-2 mRNA Expression in the Mouse Heart Endocrinology, August 1, 2001; 142(8): 3537 - 3545. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nomura, Y. Iwasaki, M. Saito, Y. Aoki, E. Yamamori, N. Ozaki, K. Tachikawa, N. Mutsuga, M. Morishita, M. Yoshida, et al. Involvement of upstream open reading frames in regulation of rat V1b vasopressin receptor expression Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E780 - E787. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kageyama, G. E. Gaudriault, M. J. Bradbury, and W. W. Vale Regulation of Corticotropin-Releasing Factor Receptor Type 2{beta} Messenger Ribonucleic Acid in the Rat Cardiovascular System by Urocortin, Glucocorticoids, and Cytokines Endocrinology, July 1, 2000; 141(7): 2285 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Myers, M. E. Bell, T. J. McDonald, and T. R. Myers Corticotropin-Releasing Factor Receptor Expression in the Pituitary of Fetal Sheep after Lesion of the Hypothalamic Paraventricular Nucleus Endocrinology, September 1, 1999; 140(9): 4292 - 4299. [Abstract] [Full Text] |
||||
![]() |
O. Marti, R. Andres, and A. Armario Defective ACTH response to stress in previously stressed rats: dependence on glucocorticoid status Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R869 - R877. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text] |
||||
![]() |
S. J. McClennen, D. N. Cortright, and A. F. Seasholtz Regulation of Pituitary Corticotropin-Releasing Hormone-Binding Protein Messenger Ribonucleic Acid Levels by Restraint Stress and Adrenalectomy Endocrinology, November 1, 1998; 139(11): 4435 - 4441. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dijkstra, F. J. H. Tilders, G. Aguilera, A. Kiss, C. Rabadan-Diehl, N. Barden, S. Karanth, F. Holsboer, and J. M. H. M. Reul Reduced Activity of Hypothalamic Corticotropin-Releasing Hormone Neurons in Transgenic Mice with Impaired Glucocorticoid Receptor Function J. Neurosci., May 15, 1998; 18(10): 3909 - 3918. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Iredale and R. S. Duman Glucocorticoid Regulation of Corticotropin-Releasing Factor1 Receptor Expression in Pituitary-Derived AtT-20 Cells Mol. Pharmacol., May 1, 1997; 51(5): 794 - 799. [Abstract] [Full Text] |
||||
![]() |
Y. Sakai, N. Horiba, K. Sakai, F. Tozawa, A. Kuwayama, H. Demura, and T. Suda Corticotropin-Releasing Factor Up-Regulates Its Own Receptor Gene Expression in Corticotropic Adenoma Cells in Vitro J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1229 - 1234. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |